Anthony C. Hooper is executive vice president, Global Commercial Operations for Amgen. In this role, he is responsible for ensuring Amgen’s innovative medicines reach patients, payers and physicians around the world.

With a successful biopharmaceutical career spanning more than 30 years, Hooper is a seasoned international executive with experience running biopharmaceutical businesses in five countries on four continents.

Prior to joining Amgen in October 2011, Hooper spent more than 15 years at Bristol-Myers Squibb Company. His last role there was senior vice president, Global Commercial Operations and president of the company’s $15 billion pharmaceutical business in the Americas, Japan and Intercontinental regions. Hooper was also assistant vice president of Global Marketing for Wyeth Laboratories. He also worked at Lederle International in New Jersey, where he led the international marketing group.

Hooper earned law and MBA degrees from the University of South Africa.